-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAVERE THERAPEUTICS, INC. : STIFEL RAISES TARGET PRICE TO $62 FROM $43

Reuters·08/05/2026 11:17:17

Please log in to view news